P361: EARLY MEASURABLE RESIDUAL DISEASE ANALYSIS IS ONLY PREDICTIVE OF SURVIVAL OUTCOMES AFTER TWO CYCLES OF TREATMENT IN ADULTS WITH B-LYMPHOBLASTIC LEUKEMIA RECEIVING HYPER-CVAD INDUCTION. (23rd June 2022) - Nedumannil, R.; Ritchie, D.; Bajel, A.; Ng, A. P.; Harrison, S. J.; Westerman, D.